LBTY.A enters the final stretch of Q3 with an unusual split: options traders have turned notably bullish while short sellers have spent the past month steadily adding to their positions.
The options signal is the sharpest read of the week. The put/call ratio has dropped to 0.42 — a full 2.1 standard deviations below its 20-day average of 0.48 — making it the lowest reading of the past year. That is an unusually lopsided lean toward calls rather than puts. The shift is particularly striking because it runs against the stock's price action: LBTY.A has fallen 5% over the past week to $9.97, and is down 6.4% over the past month.
The short-interest picture cuts the other way. Bears have been steadily rebuilding. Short interest has climbed roughly 25% over 30 days, reaching 7.1% of the free float — a meaningful position for a stock of this profile. The weekly move was modest at 1.2%, and Monday brought a one-day pullback of 3.6%, suggesting some covering at lower prices. But the trend is clear. Borrow conditions, however, offer no sign of urgency on the short side: cost to borrow runs at just 0.53%, and availability is deep at roughly 960% — meaning for every share already borrowed, there are nearly ten more sitting idle in the lending pool. Shorts face no squeeze pressure at all. Positioning looks structurally bearish in conviction but comfortable in execution.
The Street has been directionally cautious for some time. The most recent moves — Barclays cutting its target from $13 to $10 in August while holding Equal-Weight, and UBS trimming from $12.10 to $11.90 earlier that month — both reflect a pattern of sustained target compression. The consensus mean target of roughly $15.90 now sits more than 50% above the current price, but the trajectory of analyst moves has been consistently downward for over a year, draining credibility from that headline premium. The EV/EBITDA multiple of 7.9x has nudged lower over the past 30 days. Price-to-book at 0.37x reflects a deeply discounted asset base — a point the bulls, led by Benchmark's long-standing Buy with a $21 target, would flag as a structural undervaluation story. The EPS surprise factor score of 81 is a genuine bright spot: the company has beaten estimates more consistently than most of its sector peers. ORTEX's short score at 52.9 has eased from a week-ago reading above 54, suggesting some modest improvement in the aggregate short-side signal.
On the ownership side, two names stand out. ACR Alpine Capital Research holds 9.5% of shares, adding nearly 1.9 million during the last reported quarter — the largest active buyer among top holders. BlackRock and State Street both added through August. The Baupost Group, by contrast, trimmed by nearly 4.9 million shares in the June quarter — the biggest reduction among major holders. John Malone remains the second-largest named holder at 8.8% of shares. CEO Michael Fries reported a modest sale of 49,170 shares earlier in May. The ownership picture is concentrated and largely stable, though Baupost's cut is worth noting given the firm's value-oriented history with the name.
The next hard catalyst is an October 30 earnings print. The two most recent quarters produced opposite one-day moves: a 4.2% gain on July 31 and a 4.5% drop on July 24. With shorts at one-month highs and options traders leaning unusually bullish, how the results land against those divergent positioning signals is the central question heading into the release. Peers have had a rough week — CMCSA fell 8.2% and ORA dropped 9% — making Liberty Global's 5% decline look almost contained by comparison, though the sector-wide pressure is a backdrop worth watching as October approaches.
See the live data behind this article on ORTEX.
Open LBTY.A on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
